SICKLE CELL DISEASE GENE THERAPY

The Florida Department of Health has entered into a financial assistance standard contract with Suncost Communities Blood Bank, Inc. for the procurement of a specialized equipment unit. This equipment is essential for supplying the critical source product required for gene therapy research and the treatment of Sickle Cell Disease, with the ultimate goal of improving healthcare services and patient outcomes within the approved Service Area. The agreement is governed by both Florida and Federal laws, requiring strict compliance with regulations regarding the use of federal funds and the maintenance of public records. This award notice, identified by solicitation number CMOAF, establishes the operational and legal framework for the partnership to advance specialized medical research and treatment capabilities.